🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

9736+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9736 recruiting trials

Phase 3RecruitingNCT07363720

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

👨‍⚕️ Study Director, Takeda📍 7 sites📅 Started Jan 2026View details ↗
NARecruitingNCT07484490

Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis

👨‍⚕️ Nayab shahid, MS-PT, RIPHAH INTERNATINAAL UNIVERSITY📍 1 site📅 Started Jan 2026View details ↗
Phase 1, PHASE2RecruitingNCT07024316

A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP

🏥 Atlas Molecular Pharma📍 1 site📅 Started Jan 2026View details ↗
Phase 1, PHASE2RecruitingNCT07227597

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 9 sites📅 Started Jan 2026View details ↗
Phase 1RecruitingNCT07331272

A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

🏥 Nanjing Legend Biotech Co.📍 5 sites📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT06878274

Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

🏥 Centre hospitalier de l'Université de Montréal (CHUM)📍 1 site📅 Started Jan 2026View details ↗
Enrolling by InvitationNCT07474051

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

🏥 AvenCell Therapeutics, Inc.📍 5 sites📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT07234019

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jan 2026View details ↗
NARecruitingNCT06990477

Effect of EIT-guided PEEP in ARDS Patients With Higher Recruitability

🏥 Southeast University, China📍 3 sites📅 Started Jan 2026View details ↗
Phase 1, PHASE2RecruitingNCT07439887

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

🏥 Ray Therapeutics, Inc.📍 2 sites📅 Started Jan 2026View details ↗
NARecruitingNCT07191327

Testing Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy

👨‍⚕️ Benjamin Hamstead, PhD, University of Michigan📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT07225621

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

🏥 Alpheus Medical, Inc.📍 8 sites📅 Started Jan 2026View details ↗
Phase 1, PHASE2RecruitingNCT07385001

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

🏥 Tang-Du Hospital📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07258524

PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis

👨‍⚕️ Neeraj Dhaun, MBChB PhD, University of Edinburgh📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07402018

Intra-aortic Balloon Counterpulsation (IABC) Compliance

👨‍⚕️ Matthew S Delfiner, DO, MS, Thomas Jefferson University📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT06728410

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

👨‍⚕️ Mehmet Akce, MD, Sponsor-Investigator📍 1 site📅 Started Jan 2026View details ↗
Phase 3Enrolling by InvitationNCT07386587

Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

👨‍⚕️ Faisal Haneef, University of Child Health Sciences Lahore.📍 1 site📅 Started Jan 2026View details ↗
Phase 1, PHASE2RecruitingNCT07017946

Intestinal Microbiome Transplant in ALS

👨‍⚕️ Richard Bedlack, MD, PhD, Duke University📍 1 site📅 Started Jan 2026View details ↗
NARecruitingNCT07364474

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

👨‍⚕️ Eric Wehrenberg-Klee, MD, Massachusetts General Hospital📍 1 site📅 Started Jan 2026View details ↗
Phase 1RecruitingNCT07172958

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

👨‍⚕️ Holly Meany, MD, Children's National Research Institute📍 2 sites📅 Started Jan 2026View details ↗
← PreviousPage 19 of 487Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →